JPRN-UMIN000022897已完成未知
Rituximab induction for liver transplantation to prevent recurrence of primary sclerosing cholangitis - Rituximab induction for liver transplantation to prevent recurrence of primary sclerosing cholangitis
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 2years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Re-trenaplantation Deceased donor transplantation, Domino Transplantation
研究者
相似试验
进行中（未招募）
1 期
autologous Transplantation after a Rituximab/Ibrutinib/Ara-c containing iNduction in Generalized mantle cell Lymphoma – a randomized European MCL Network trialEUCTR2014-001363-12-PLKlinikum der Universität München, Medizinische Klinik und Poliklinik III870
进行中（未招募）
1 期
autologous Transplantation after a Rituximab/Ibrutinib/Ara-c containing iNduction in Generalized mantle cell Lymphoma – a randomized European MCL Network trialGeneralized mantle cell LymphomaMedDRA version: 21.0Level: PTClassification code 10026805Term: Mantle cell lymphoma stage IVSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: PTClassification code 10026804Term: Mantle cell lymphoma stage IIISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: PTClassification code 10026803Term: Mantle cell lymphoma stage IISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2014-001363-12-NLKlinikum der Universität München, Medizinische Klinik und Poliklinik III870
进行中（未招募）
1 期
autologous Transplantation after a Rituximab/Ibrutinib/Ara-c containing iNduction in Generalized mantle cell Lymphoma – a randomized European MCL Network trialGeneralized mantle cell LymphomaMedDRA version: 20.0 Level: PT Classification code 10026805 Term: Mantle cell lymphoma stage IV System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0 Level: PT Classification code 10026804 Term: Mantle cell lymphoma stage III System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0 Level: PT Classification code 10026803 Term: Mantle cell lymphoma stage II System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2014-001363-12-FIKlinikum der Universität München, Medizinische Klinik und Poliklinik III870
进行中（未招募）
1 期
autologous Transplantation after a Rituximab/Ibrutinib/Ara-c containing iNduction in Generalized mantle cell Lymphoma – a randomized European MCL Network trialPreviously untreated mantle cell LymphomaMedDRA version: 21.0Level: PTClassification code 10026805Term: Mantle cell lymphoma stage IVSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: PTClassification code 10026804Term: Mantle cell lymphoma stage IIISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: PTClassification code 10026803Term: Mantle cell lymphoma stage IISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2014-001363-12-DKKlinikum der Universität München, Medizinische Klinik und Poliklinik III870
进行中（未招募）
1 期
autologous Transplantation after a Rituximab/Ibrutinib/Ara-c containing iNduction in Generalized mantle cell Lymphoma – a randomized European MCL Network trialGeneralized mantle cell LymphomaMedDRA version: 21.0Level: PTClassification code 10026805Term: Mantle cell lymphoma stage IVSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: PTClassification code 10026804Term: Mantle cell lymphoma stage IIISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: PTClassification code 10026803Term: Mantle cell lymphoma stage IISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2014-001363-12-BEKlinikum der Universität München, Medizinische Klinik und Poliklinik III870